Infectious Diseases - Researchers map malaria parasites in unprecedented cellular detail
Can't see this email? View it online
   
  Infectious Diseases  
  The latest infectious diseases news from News Medical  
 

Johns Hopkins researchers warn of new infectious diseases and death due to global warmingA Convenient Method to Evaluate Vaccine Efficacy against SARS-CoV-2 Variants of Concern

 

While a growing number of people are getting vaccinated to acquire protection against SARS-CoV-2, the original wild-type virus is evolving to acquire increased fitness that may help evade vaccine-induced immune surveillance. In face of this “Red Queen” challenge, how strong the current vaccine protection is against the circulating and emerging variants of the virus becomes a primary concern.

ACROBio is excited and proud to introduce a series of neutralizing antibody titer kits specifically designed for the SARS-CoV-2 variants of concern (VOC) to you!

  • Based on a competitive ELISA method
  • Detect neutralizing antibodies which can specifically inhibit the binding of mutated RBD/ Spike to ACE2
  • High throughput and convenient to evaluate vaccine efficacy against SARS-CoV-2 VOC
Find Out More
 
   Researchers map malaria parasites in unprecedented cellular detailResearchers map malaria parasites in unprecedented cellular detail
 
Researchers have mapped in fine detail the genetic changes malaria parasites go through as they prepare to infect people.
 
   Researcher investigates the behavior and life cycle of most infectious pathogenic bacteriaResearcher investigates the behavior and life cycle of most infectious pathogenic bacteria
 
Although it is not spread through human contact, Francisella tularensis is one of the most infectious pathogenic bacteria known to science
 
 Neurocognitive symptoms persist 6 months post-infection with long COVID
 
Neurocognitive symptoms persist 6 months post-infection with long COVIDAccording to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
 
 
 Novel SARS-CoV-2 variants partially resistant to infection- and vaccine-induced immunity, study finds
 
Novel SARS-CoV-2 variants partially resistant to infection- and vaccine-induced immunity, study findsA recent study conducted by a team of scientists in the Netherlands has revealed that while severely affected hospitalized COVID-19 patients and vaccinated individuals are capable of neutralizing the B.1.1.7, B.1.351, and P.1 variants of SARS-CoV-2, a significant proportion of non-hospitalized patients with less severe COVID-19 remain susceptible to these viral variants.
 
 
 Are women more likely to develop long COVID?
 
Are women more likely to develop long COVID?Researchers found different groups of symptoms persisting after coronavirus disease 2019 (COVID-19), with fatigue and higher IL-6 levels common in women. About 75% of the patients they treated were women, indicating a link between sex hormones and immune response.